JACKSON, Wyo.--(BUSINESS WIRE)--Brand Engagement Network (“BEN”), an emerging provider of personalized customer engagement AI technology and human-like AI avatars, today announced the appointment of Dr. Richard S. Isaacs, MD as medical advisor to its board of directors. Dr. Isaacs is a renowned otolaryngologist, head, neck and skull base surgeon and is currently serving as Dean of the College of Medicine and Professor of Otolaryngology (head and neck oncologic surgery) at California Northstate University, previously having served as the Chief Executive Officer of The Permanente Group for over six years.
In his role as medical advisor, we believe Dr. Isaacs will bring deep expertise in the medical and healthcare verticals, as well as a broad network, to BEN at a pivotal time as BEN continues towards the consummation of its previously announced business combination with DHC Acquisition Corp. (Nasdaq: DHCA) and public listing on the Nasdaq Capital Market. DHC filed its Form S-4 Registration Statement with the Securities and Exchange Commission on October 17, 2023 - marking another critical milestone in BEN’s march towards its public listing on the Nasdaq Capital Market.
Michael Zacharski, CEO of BEN, said:
“We’re thrilled to welcome Dr. Isaacs, a highly influential physician leader and healthcare executive to the BEN team. We believe his extensive expertise in both practicing and teaching medicine as well as running one of the nation’s largest medical groups will be invaluable in helping us achieve our mission of revolutionizing the healthcare industry with our conversational AI platform and human like AI interface.”
Dr. Richard S. Isaacs, MD said:
“AI has the potential to transform healthcare by supporting the current workforce, expanding access to care, and bridging the health equity gap. The BEN team is well-equipped to fulfill these promises, as their avatar is highly interactive and genuinely attentive, showcasing what I believe will be an unmatched level of compassion and empathy.”
About DHC Acquisition Corp.
DHC Acquisition Corp. (Nasdaq: DHCA) is a special purpose acquisition company (SPAC) focused on partnering with an innovative technology company. DHC’s mission is to invest in companies which are charting the future of how humans and business interact at the last mile, spanning enterprise infrastructure, industrial IoT, automation, retail and E-commerce infrastructure, automotive, and aerospace. We endeavour to enable the applications of innovative technology and business models which bring goods, people, or information to its final destination.
DHC’s approach to business is based on teamwork, integrity and quiet professionalism, qualities we learned during our extensive training in the military. We bring our unique hybrid experience and our values into the corporate world, building high performing teams in a range of specialized industries: technology, consumer, aviation, defense, automotive, investment banking, capital markets, and asset management. Our collective experience includes: >25 years as CEOs of public companies, 8 companies founded, 13 companies acquired, and >55 years in military leadership.
Important Information About the Business Combination and Where to Find It
In connection with the BEN’s announcement of its intent to go public via a merger with DHC Acquisition Corp. (“DHC”) (the “Business Combination”), DHC has filed a registration statement on Form S-4 (the “Form S-4”) with the SEC, which will serve as a preliminary proxy statement of DHC. DHC will mail a definitive proxy statement and other relevant documents to its shareholders. DHC’s shareholders and other interested persons are advised to read, when available, the preliminary proxy statement and any amendments thereto and the definitive proxy statement and documents incorporated by reference therein filed in connection with the Business Combination, as these materials will contain important information about DHC, BEN and the Business Combination. When available, the definitive proxy statement and other relevant materials for the Business Combination will be mailed to shareholders of DHC as of a record date to be established for voting on the Business Combination. INVESTORS ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT AND OTHER RELEVANT MATERIALS CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT DHC, BEN AND THE BUSINESS COMBINATION. Shareholders will also be able to obtain copies of the Form S-4, preliminary proxy statement, the definitive proxy statement and other documents filed with the SEC that will be incorporated by reference therein, without charge, once available, at the SEC’s website at www.sec.gov, or by directing a request to: DHC Acquisition Corp., 1900 West Kirkwood Blvd, Suite 1400B, Southlake, TX 76092 or by emailing chris@integrity.partners.
Participants in the Solicitation
DHC, BEN and certain of their directors and executive officers may be deemed participants in the solicitation of proxies from DHC’s shareholders with respect to the Business Combination. A list of the names of those directors and executive officers and a description of their interests in the Business Combination will be set forth in the Form S-4. Certain information regarding the directors and executive officers of DHC is contained in its Annual Report on Form 10-K for the fiscal year ended December 31, 2022. These documents can be obtained free of charge from the sources indicated above.